News & Articles

Emergency Use Listing granted to AstraZeneca and Serum Institute of India enabling global access to the vaccine

Focusing on innate immunity opens way for precision medicine approaches to AD

Company expands portfolio of SARS-CoV-2 testing solutions with rapid antigen test benchmarked against gold standard RT-PCR

Eight-marker panel, including new long mononucleotide repeat (LMR) markers, enables broader view of mismatch repair deficiency

Discover the latest technologies and techniques to aid research into the biology, detection, and prevention of SARS-CoV-2 infection

New partnership broadens access to oncology treatments across Latin America, Asia, Africa and the Western Pacific

Partnership aims to accelerate CE marking of Avacta’s SARS-CoV-2 rapid antigen test and support COVID-19 testing

The test could be used to assess antibody response against the native spike protein of SARS-CoV-2 following COVID-19 vaccination

This effort will study virus variants in the UK and South Africa and what that means for the transmission of SARS-CoV-2

Researchers have used Test and Trace data to find out why some individuals pass COVID-19 on to their contacts more easily than others

Advancement can enable greater certainty for providers and better outcomes for patients

Expanded list of instruments and reagents allows more options for labs running CDC Influenza SARS-CoV-2 (Flu SC2) Multiplex Assay

In this on-demand webinar, discover how to rapidly diagnose antimicrobial resistance for appropriate therapy

The extraction-free saliva-based test detects nucleic acid from the SARS-CoV-2 virus

The acquisition aims to meet continuing demand for COVID-related testing as well as develop point-of care tests for future infectious diseases

The collaboration aims to advance the scale-up of hMSC manufacturing for regenerative medicine

Developed in partnership with Rosetta Biosciences, discovery enables simultaneous detection of multiple targets, furthering next generation of diagnostics

The strategic collaboration aims to accelerate clinical trials and drive critical developments for promising COVID-19 treatments

The new institute aims to meet the urgent need to do more research into the antimicrobial resistance

Panel supports research to distinguish between types of chronic inflammatory airway disease including asthma, COPD and IPF

The integrated solution offers deeper insight into therapy resistance and relapse, saving billions in drug development costs

Watch this on-demand webinar to learn about the potential of computer-assisted interpretation and linking disease markers identified by NMR to the metagene database

Precision dosing of the liquid therapy is very important as it must correspond to each patient’s addiction level